Narrow search
Showing 71 - 80 of 65,451
Cover Image
Persuasion or information? : promotion and the shares of brand name and generic pharmaceuticals
Hurwitz, Mark A. - In: The journal of law & economics 31 (1988) 2, pp. 299-320
Persistent link: https://www.econbiz.de/10001056403
Cover Image
The brand name prescription drug litigation : comments on Scherer
Harrison, Jeffrey L. - In: International journal of the economics of business 4 (1997) 3, pp. 265-269
Persistent link: https://www.econbiz.de/10001336966
Cover Image
Characteristics of demand for pharmaceutical products : an examination of four cephalosporins
Ellison, Sara Fisher (contributor) - In: The Rand journal of economics 28 (1997) 3, pp. 426-446
Persistent link: https://www.econbiz.de/10001226244
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2010
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and …
Persistent link: https://www.econbiz.de/10013139185
Cover Image
FAS 142 : Developing a Framework for Assessing the Useful Life of Branded Pharmaceutical Products
Duchac, Jonathan E. - 2012
In 2001 the Financial Accounting Standards Board issued FAS 142 Goodwill and Intangible Assets, which expanded the accounting guidance for intangible assets. These changes were particularly significant for companies in industries that rely heavily on intellectual capital to generate future cash...
Persistent link: https://www.econbiz.de/10013108848
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2013
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and …
Persistent link: https://www.econbiz.de/10013088216
Cover Image
Do Pharmacists Buy Bayer? Sophisticated Shoppers and the Brand Premium
Bronnenberg, Bart J. - 2016
We estimate the effect of information on consumers' willingness to pay for branded goods in physically homogeneous consumer packaged goods categories. In a case study of headache remedies, we find that college education, working in a healthcare occupation, and other proxies for product knowledge...
Persistent link: https://www.econbiz.de/10013006238
Cover Image
Do Pharmacists Buy Bayer? Informed Shoppers and the Brand Premium
Bronnenberg, Bart J. - 2014
suggest that misinformation and related consumer mistakes explain a sizable share of the brand premium for health products …
Persistent link: https://www.econbiz.de/10013050309
Cover Image
Consumer decision making from a beloved brand : the Aspirin case
Borges, Ana Pinto; Rodrigues, Paula Cristina Lopes - In: New techniques for brand management in the healthcare sector, (pp. 184-198). 2021
Persistent link: https://www.econbiz.de/10012516044
Cover Image
The competitive impact of branded generic medicine in a developing country
Álvarez, Roberto; González, Aldo; Fernández, Sebastian - 2019
Persistent link: https://www.econbiz.de/10012659663